Point72 Asset Management L.P. 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:19 pm Sale |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
Point72 Asset Management L.P. | 1,178,501 1.900% |
-1,828,637 (-60.81%) |
Filing |
| 2022-02-14 4:37 pm Purchase |
2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
Point72 Asset Management L.P. | 3,007,138 5.800% |
365,885 (+13.85%) |
Filing |
| 2021-10-28 5:24 pm Purchase |
2021-10-27 | 13G | Xenon Pharmaceuticals Inc. XENE |
Point72 Asset Management L.P. | 2,641,253 5.100% |
2,641,253 (New Position) |
Filing |